Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Journey Medical (DERM) Total Liabilities (2020 - 2026)

Journey Medical filings provide 6 years of Total Liabilities readings, the most recent being $62.7 million for Q4 2025.

  • On a quarterly basis, Total Liabilities rose 4.26% to $62.7 million in Q4 2025 year-over-year; TTM through Dec 2025 was $62.7 million, a 4.26% increase, with the full-year FY2025 number at $62.7 million, up 4.26% from a year prior.
  • Total Liabilities hit $62.7 million in Q4 2025 for Journey Medical, up from $59.3 million in the prior quarter.
  • In the past five years, Total Liabilities ranged from a high of $100.8 million in Q3 2021 to a low of -$10.8 million in Q1 2021.
  • Median Total Liabilities over the past 5 years was $61.0 million (2024), compared with a mean of $60.3 million.
  • Biggest five-year swings in Total Liabilities: soared 9836.99% in 2022 and later plummeted 40.77% in 2023.
  • Journey Medical's Total Liabilities stood at $55.2 million in 2021, then surged by 59.62% to $88.2 million in 2022, then crashed by 35.93% to $56.5 million in 2023, then increased by 6.5% to $60.2 million in 2024, then increased by 4.26% to $62.7 million in 2025.
  • The last three reported values for Total Liabilities were $62.7 million (Q4 2025), $59.3 million (Q3 2025), and $61.9 million (Q2 2025) per Business Quant data.